Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase Ill Multicenter Randomized Controlled Trial

被引：0
|
作者：
Murthy, V. [1 ]
Maitre, P. [1 ]
Pal, M. [1 ]
Sharma, R. [2 ]
Pujari, L. [3 ,4 ]
Pandey, H. [3 ,4 ]
Gudipudi, D. [2 ]
Bandekar, B. [3 ,4 ]
Joseph, D. M. [5 ]
Mehta, P. S. [1 ]
Krishnatry, R. [1 ]
Singh, P. [1 ]
Phurailatpam, R. [1 ]
Arora, A. [1 ]
Joshi, A. [1 ]
Noronha, V. [1 ]
Prabhash, K. [1 ]
Menon, S. [1 ]
Bakshi, G. [1 ]
Prakash, G. [1 ]
机构：
[1] Homi Bhabha Natl Inst, Tata Mem Ctr, Mumbai, Maharashtra, India
[2] Basavatarakam Indoamer Canc Hosp & Res Inst, Hyderabad, India
[3] Homi Bhabha Natl Inst, Mahamana Pandit Madan Mohan Malaviya Canc Ctr, Varanasi, Uttar Pradesh, India
[4] Homi Bhabha Natl Inst, Homi Bhabha Canc Hosp, Varanasi, Uttar Pradesh, India
[5] All India Inst Med Sci, Dehra Dun, Uttarakhand, India
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA 04
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
    Murthy, Vedang
    Maitre, Priyamvada
    Bakshi, Ganesh
    Pal, Mahendra
    Singh, Maneesh
    Sharma, Rakesh
    Gudipudi, Duleep
    Pujari, Lincoln
    Pandey, Himanshu
    Bandekar, Bhavesh
    Joseph, Deepa
    Krishnatry, Rahul
    Phurailatpam, Reena
    Kannan, Sadhana
    Arora, Amandeep
    Misra, Ankit
    Joshi, Amit
    Noronha, Vanita
    Prabhash, Kumar
    Menon, Santosh
    Prakash, Gagan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (03): : 728 - 736
  • [2] Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer
    Murthy, V.
    Maitre, P.
    Singh, M.
    Pal, M.
    Arora, A.
    Pujari, L.
    Kapoor, A.
    Pandey, H.
    Sharma, R.
    Gudipudi, D.
    Joshi, A.
    Prabhash, K.
    Noronha, V.
    Menon, S.
    Mehta, P.
    Bakshi, G.
    Prakash, G.
    CLINICAL ONCOLOGY, 2023, 35 (09) : e506 - e515
  • [3] Acute and Late Toxicity in Radical Radiotherapy for Bladder Cancer
    Majewski, W.
    Tarnawski, R.
    CLINICAL ONCOLOGY, 2009, 21 (08) : 598 - 609
  • [4] Temporal patterns of late bowel and bladder radiotherapy toxicity in a randomised controlled trial assessing duration of neo-adjuvant hormones in prostate cancer
    Barry, Aisling S.
    Dunne, Mary T.
    Lyons, Ciara A.
    Finn, Marie A.
    Moulton, Brian
    Taylor, Judy C.
    O'Shea, Carmel M.
    Thirion, Pierre G.
    Armstrong, John G.
    ACTA ONCOLOGICA, 2014, 53 (10) : 1390 - 1397
  • [5] Is there a relationship between acute and late toxicity in radiotherapy for bladder cancer?
    Majewski, W
    Majewski, S
    Maciejewski, B
    Tarnawski, R
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S98 - S98
  • [6] Acute and late morbidity in a Phase II trial of adaptive radiotherapy for urinary bladder cancer
    Vestergaard, A.
    Muren, L.
    Lindberg, H.
    Dysager, L.
    Jakobsen, K.
    Jensen, H.
    Petersen, J.
    Elstrom, U.
    Als, A.
    Hoyer, M.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S291 - S292
  • [7] The Finnish Randomized Trial of Adjuvant Radiotherapy Versus Observation After Prostatectomy: Almost a Trial of Adjuvant Versus Late Salvage Radiotherapy
    Spratt, Daniel E.
    EUROPEAN UROLOGY, 2019, 76 (05) : 596 - 598
  • [8] Multicenter phase II trial of preoperative radiotherapy with concurrent and adjuvant capecitabine
    Sauer, R
    Hipp, M
    Liersch, T
    Arnold, D
    Rödel, C
    ANNALS OF ONCOLOGY, 2006, 17
  • [9] Adjuvant radiotherapy after curative resection of hepatocellular carcinoma with narrow margin (≤1 cm): A phase 2, multicenter, randomized controlled trial.
    Ming, Kuang
    Peng, Zhenwei
    Chen, Zebin
    Shen, Shunli
    Li, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 722 - 722
  • [10] Adjuvant capecitabine in locoregionally advanced nasopharyngeal carcinoma: A multicenter randomized controlled phase III trial.
    Miao, Jingjing
    Wang, Lin
    Tan, Sze Huey
    Li, Jin-Gao
    Yi, Junlin
    Zhang, Ye
    Gong, Xiaochang
    Xiang Yanqun
    Chen, Qiu-Yan
    Chen, Mingyuan
    Lv, Xing
    Xia, Weixiong
    Tang, Lin-Quan
    Deng, Xiao-Wu
    Guo, Xiang
    Mai, Hai-Qiang
    Han, Fei
    Chua, Melvin Lee Kiang
    Zhao, Chong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345